XLRN

Acceleron Pharma Inc
178.75
0.00 (0.0%)

Acceleron Pharma Inc. (XLRN) Fundamentals

Acceleron Pharma is a biotechnology company focused on the discovery, development, and commercialization of novel therapies. The company's research focuses on key natural regulators of cellular growth and repair. Acceleron generates its revenue through collaboration, licensing, and research arrangements with collaboration partners for the development and commercialization of therapeutic candidates. The company sometimes uses contract research organizations and research institutions outside the United States.
SHARE INFORMATION
Market CapUS$ 10,931,603,898
Shares Outstanding61,155,826
Float54,014,190
Percent Float88.32%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 92,524,000
Latest Fiscal EPSUS$ -2.92
Latest Fiscal Date2020-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions654
Institutional Holdings Date2021-10-31
Institutional Bought Previous 3 Months4,004,893
Institutional Holdings Percent158.6%
Institutional Sold Previous 3 Months9,411,678
Insider Holdings Date2021-10-31
Insider Bought Previous 3 Months16,650
Insider Holdings Percent1.7
Insider Sold Previous 3 Months35,300
Insider Shares Owned1,035,466
TRADING INFO
52 Week HighUS$ 189.99
52 Week LowUS$ 110.72
52 Week High ChangeUS$ 57.43
21 Day Moving AverageUS$ 174.6629
21 Day Extended Moving AverageUS$ 174.7139
50 Day Moving AverageUS$ 169.4926
50 Day Extended Moving AverageUS$ 166.6528
200 Day Moving AverageUS$ 137.9148
200 Day Extended Moving AverageUS$ 141.0716
10 Day Average Volume1,906,574
20 Day Average Volume1,267,325
30 Day Average Volume1,102,513
50 Day Average Volume1,449,881
Alpha0.038529
Beta0.1320
Standard Deviation0.148517
R20.001546
7 Day Price ChangeUS$ 5.25
7 Day Percent Change3.03%
21 Day Price ChangeUS$ 4.88
21 Day Percent Change2.81%
30 Day Price ChangeUS$ 4.80
30 Day Percent Change2.76%
Month to Date Price ChangeUS$ 4.57
Month to Date Percent Change2.62%
Quarter to Date Price ChangeUS$ 6.65
Quarter to Date Percent Change3.86%
180 Day Price ChangeUS$ 49.07
180 Day Percent Change37.84%
200 Day Price ChangeUS$ 56.92
200 Day Percent Change46.72%
Year to Date Price ChangeUS$ 50.81
Year to Date Percent Change39.71%

Acceleron Pharma Inc. (XLRN) Key Ratios

PROFITABILITY
EBIT Margin-226.6%
EBITDA Margin-222.8%
Pre-Tax Profit Margin-441.5%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 112,764,000
Revenue Per ShareUS$ 1.8439
Revenue (3 Years)US$ 97.68
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book15.20
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio12.10
Leverage Ratio1.10
Quick Ratio10.90
Long Term Debt To Capital0.02
VALUATION MEASURES
PE Ratio-42.30
Enterprise ValueUS$ 10,361,148,897
Price to Sales96.9423
Price to Free Cash-41.00
PE High Last 5 Years-20.80
Price To Book15.20
Price To Cash Flow0.00
PE Low Last 5 Years-21.00
Price to Tangible Book15.20
MANAGEMENT EFFECTIVENESS
Receivables Turnover4.80
Invoice Turnover0.00
Assets Turnover0.20
Return Assets-29.57
Return on Equity-31.82
Return on Capital-30.79

Acceleron Pharma Inc. (XLRN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOHabib J. Dable
Emplyoees312
Last AuditUE
CIK0001280600
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address128 Sidney Street
Cambridge, MA 2139
Websitehttp://www.acceleronpharma.com
Facsimile+1 617 649-9988
Telephone+1 617 649-9200
EmailInvestor@acceleronpharma.com
Your Recent History
NASDAQ
XLRN
Acceleron ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230401 11:05:01